Atossa Therapeutics (ATOS) FCF Margin (2011 - 2015)
Atossa Therapeutics (ATOS) reported FCF Margin of -213903.30% for Q4 2015, down 123307.98 percentage points from -90595.32% a year earlier.
Powered by 
Analysis
Atossa Therapeutics (ATOS) FCF Margin (2011 - 2015) Analysis & Trends
For FY2015, Atossa Therapeutics posted FCF Margin of -801139.42%, down 775237.46 percentage points from FY2014.
- FCF Margin has declined for three consecutive years, with a four-year change of -562550.82 percentage points (FY2011 to FY2015).
- By year, FCF Margin came in at -25901.96% in FY2014 (-24467.39 pp), -1434.57% in FY2013 (-603.48 pp), -831.09% in FY2012 (+237757.51 pp) and -238588.60% in FY2011.
- The Q4 2015 figure ranks as the lowest quarterly FCF Margin in data going back to Q4 2011.
- The high point for year-over-year FCF Margin in five years was Q4 2012 (a gain of 70550.20 percentage points); the low point was Q4 2015 (a drop of 123307.98 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Atossa Therapeutics | 19.96 Mn | -131.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | -213,903.30% |
| Dec 31, 2014 | -90,595.32% |
| Sep 30, 2014 | -89,308.29% |
| Jun 30, 2014 | -23,007.79% |
| Mar 31, 2014 | -10,806.48% |
| Dec 31, 2013 | -5,393.47% |
| Sep 30, 2013 | -3,920.01% |
| Jun 30, 2013 | -671.82% |
| Mar 31, 2013 | -730.72% |
| Dec 31, 2012 | -2,068.86% |
| Sep 30, 2012 | -143.01% |
| Jun 30, 2012 | -363.74% |
| Mar 31, 2012 | -1,837.13% |
| Dec 31, 2011 | -72,619.07% |
API Access
Atossa Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();